Adiposogenital dystrophy vision test

Revision as of 04:16, 29 December 2021 by Nnabude (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy vision test On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy vision test

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy vision test

CDC on Adiposogenital dystrophy vision test

Adiposogenital dystrophy vision test in the news

Blogs on Adiposogenital dystrophy vision test

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy vision test

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

Visual impairment may be seen in adiposogenital dystrophy.

Vision Test

Patients may suffer from bitemporal hemianopsia due to compression of the optic chiasm by a pituitary tumor. This can be revealed on visual field tests[1]. Patients may also have vision loss in one eye. Less commonly, patients may have visual impairment in both eyes that can be severe enough to render the patient legally blind[2]. Color vision is often affected in craniopharyngiomas[3].

References

  1. Britannica, T. Editors of Encyclopaedia (1998, July 20). Fröhlich's syndrome. Encyclopedia Britannica. https://www.britannica.com/science/Frohlichs-syndrome
  2. Wan MJ, Zapotocky M, Bouffet E, Bartels U, Kulkarni AV, Drake JM (2018). "Long-term visual outcomes of craniopharyngioma in children". J Neurooncol. 137 (3): 645–651. doi:10.1007/s11060-018-2762-3. PMID 29344823.
  3. Repka MX, Miller NR, Miller M (1989). "Visual outcome after surgical removal of craniopharyngiomas". Ophthalmology. 96 (2): 195–9. doi:10.1016/s0161-6420(89)32914-9. PMID 2704538.

Template:WH Template:WS